13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001527166
Total reported value
$10.0B
$10.0B
27 檔
40.4%
As reported in its official Q4 2024 Form 13F filing, Carlyle Group Inc.'s tracked investment portfolio stood at $10.0B with 27 total positions.
Carlyle Group Inc. executed strategic sector rebalancing during Q4 2024, establishing 7 new positions while fully exiting 6 holdings and trimming 4 positions.
In terms of portfolio concentration, the top 5 core holdings (including SARO, SLNOEUR, WRD) accounted for 40.4% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SARO | Standardaero Inc | Stock-Other | 93.20% | +4.72% | — | |
| 2 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 1.49% | — | -66.21% | |
| 3 | WRD | Weride Inc-adr | Stock-Other | 1.17% | — | — | |
| 4 | PONY | Pony Ai Inc | Stock-Other | 0.82% | -0.05% | — | |
| 5 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.68% | +0.01% | — | |
| 6 | JSPR | Jasper Therapeutics Inc | Stock-Other | 0.55% | -0.01% | — | |
| 7 | GETY | Getty Images Holdings Inc | Stock-Other | 0.45% | — | -5.73% | |
| 8 | INVH | Invitation Homes Inc | Stock-Real Estate | 0.37% | +0.04% | — | |
| 9 | CUBE | Cubesmart | Stock-Real Estate | 0.23% | -0.08% | EXIT | |
| 10 | SMHI | Seacor Marine Holdings Inc | Stock-Other | 0.21% | — | +1.81% | |
| 11 | FWRDUSD | Forward Air CORP | Stock-Other | 0.10% | — | — | |
| 12 | XCUR | Exicure Inc | Stock-Other | 0.09% | — | EXIT | |
| 13 | ✓ | Hillevax Inc | Stock-Other | 0.09% | — | — | |
| 14 | QTTB | Q32 Bio Inc | Stock-Other | 0.09% | -0.06% | — | |
| 15 | SPWR | Sunpower Inc | Stock-Other | 0.09% | +0.01% | -59.51% | |
| 16 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.08% | — | — | |
| 17 | DNUT | Krispy Kreme Inc | Stock-Other | 0.08% | — | — | |
| 18 | TORCEUR | Adicet Bio Inc | Stock-Other | 0.07% | — | — | |
| 19 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 0.06% | — | — | |
| 20 | SPRU | Spruce Power Holding Corporation | Stock-Other | 0.03% | — | — | |
| 21 | NABL | N-able Inc | Stock-Other | 0.02% | — | — | |
| 22 | CART | Maplebear Inc | Stock-Consumer Disc | 0.01% | — | -39.98% | |
| 23 | REPX | Riley Exploration Permian In | Stock-Other | 0.01% | +0.01% | NEW | |
| 24 | HOOD | Robinhood Markets Inc - A | Stock-Financials | 0.01% | — | — | |
| 25 | SYRE | Spyre Therapeutics Inc | Stock-Other | 0.01% | — | EXIT | |
| 26 | METC | Ramaco Resources Inc-a | Stock-Other | — | — | NEW | |
| 27 | ✓ | Nucana PLC | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SARO | Standardaero Inc | +93.2% | NEW | New buy |
| 2 | WRD | Weride Inc-adr | +1.2% | NEW | New buy |
| 3 | PONY | Pony Ai Inc | +0.8% | NEW | New buy |
| 4 | OKUR | Onkure Therapeutics Inc-a | +0.1% | NEW | New buy |
| 5 | REPX | Riley Exploration Permian In | 0% | NEW | New buy |
| 6 | HOOD | Robinhood Markets Inc - A | 0% | NEW | New buy |
| 7 | METC | Ramaco Resources Inc-a | — | NEW | New buy |
| 8 | MTEMEUR | Molecular Templates Inc | — | EXIT | Sold out |
| 9 | XCUR | Exicure Inc | 0% | +399.99% | Add |
| 10 | SYRE | Spyre Therapeutics Inc | 0% | — | Unchanged |
| 11 | ✓ | Nucana PLC | 0% | — | Unchanged |
| 12 | CART | Maplebear Inc | -0.1% | -39.98% | Trim |
| 13 | AVGO | Broadcom Inc | -0.1% | EXIT | Sold out |
| 14 | NABL | N-able Inc | -0.1% | — | Unchanged |
| 15 | SPRU | Spruce Power Holding Corporation | -0.1% | — | Unchanged |
| 16 | 0OIA | Solarwinds CORP | -0.1% | EXIT | Sold out |
| 17 | ✓ | Hillevax Inc | -0.3% | — | Unchanged |
| 18 | EM | Smart Share Global LTD - Adr | -0.3% | — | Unchanged |
| 19 | DNUT | Krispy Kreme Inc | -0.3% | — | Unchanged |
| 20 | FWRDUSD | Forward Air CORP | -0.3% | — | Unchanged |
| 21 | TORCEUR | Adicet Bio Inc | -0.4% | — | Unchanged |
| 22 | ✓ | Reneo Pharmaceuticals Inc | -0.5% | EXIT | Sold out |
| 23 | CUBE | Cubesmart | -1% | — | Unchanged |
| 24 | SMHI | Seacor Marine Holdings Inc | -1.1% | +1.81% | Add |
| 25 | SPWR | Sunpower Inc | -1.4% | -59.51% | Trim |
| 26 | INVH | Invitation Homes Inc | -1.4% | — | Unchanged |
| 27 | JSPR | Jasper Therapeutics Inc | -1.5% | — | Unchanged |
| 28 | GETY | Getty Images Holdings Inc | -3.2% | -5.73% | Trim |
| 29 | QTTB | Q32 Bio Inc | -5% | — | Unchanged |
| 30 | PHAT | Phathom Pharmaceuticals Inc | -5.9% | — | Unchanged |
| 31 | GTM | Zoominfo Technologies Inc | -12.6% | EXIT | Sold out |
| 32 | SLNOEUR | Soleno Therapeutics Inc | -20% | -66.21% | Trim |
| 33 | QDEL | Quidelortho CORP | -39.5% | EXIT | Sold out |
According to official SEC Form 13F filings, Carlyle Group Inc. reported a total U.S. public equity portfolio value of $10.0B across 27 disclosed positions in Q4 2024.
During Q4 2024, Carlyle Group Inc.'s top holdings by market value included SARO (93.2%)、SLNOEUR (1.5%)、WRD (1.2%). The largest single position, SARO, represented 93.2% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
SARO
市值: $3.9B
Top Position Liquidated / Trimmed
QDEL
前期市值: $376.7M
In Q4 2024, Carlyle Group Inc. made 19 total portfolio adjustments, initiating 7 new buys, adding to 2 positions, trimming 4 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.